Skip to main content

Neuromed Licenses Aureus Pharma's Ion Channel Database

NEW YORK (GenomeWeb News) - Neuromed has licensed an Aureus Pharma database for use in its drug-development programs, Aureus said today.
 
Under the agreement, Neuromed will use the company’s AurScope Ion Channel database to support development of its chronic pain drugs.
 
AurScope contains information from the scientific literature that can be used to study "all known" ion channels that apply to "all stages of the drug discovery process," Aureus said.
 
Financial terms of the agreement were not released.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.